Atlas Trials

Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Clinical trial NCT01528085 · COMPLETED

Trial details

NCT number
NCT01528085
Sponsor
Goethe University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia
Start date
2012-01-01
Primary completion
2020-03-10
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.